Aurora Cannabis Inc. (NASDAQ:ACB) Sees Significant Growth in Short Interest

Aurora Cannabis Inc. (NASDAQ:ACB) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 2,730,000 shares, an increase of 8.3% from the August 31st total of 2,520,000 shares. Based on an average trading volume of 1,330,000 shares, the short-interest ratio is presently 2.1 days. Approximately 5.0% of the shares of the stock are short sold.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Cubist Systematic Strategies LLC purchased a new position in shares of Aurora Cannabis during the second quarter worth about $50,000. Baader Bank Aktiengesellschaft lifted its position in Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after buying an additional 12,481 shares during the last quarter. Cetera Advisors LLC bought a new stake in Aurora Cannabis in the 1st quarter worth approximately $59,000. Toronto Dominion Bank lifted its position in Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Finally, Concurrent Investment Advisors LLC bought a new position in Aurora Cannabis during the first quarter valued at approximately $90,000. Hedge funds and other institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Stock Up 1.6 %

Shares of NASDAQ ACB opened at $5.84 on Monday. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35. The company has a current ratio of 3.76, a quick ratio of 2.03 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $318.55 million, a price-to-earnings ratio of -4.17 and a beta of 1.86. The business has a 50-day moving average of $6.05 and a 200-day moving average of $5.94.

Aurora Cannabis (NASDAQ:ACB) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.24. Aurora Cannabis had a negative return on equity of 7.00% and a negative net margin of 14.46%. The company had revenue of $67.27 million during the quarter, compared to analyst estimates of $55.98 million. Sell-side analysts expect that Aurora Cannabis will post -0.37 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.